BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Hana Biosciences, Inc. Receives Orphan Drug Designation For Ropidoxuridine (IPdR), For The Treatment Of Malignant Glioma

  June 9, 2006

   · 

  4 min read
• Genetown

  Curis, Inc. Initiates Strategic Plan Focused On Later-Stage Drug Development

  June 9, 2006

   · 

  1 min read
• Pharm Country

  BioWa To Present At The Biotechnology Industry Organization (BIO) VentureForum East 2006 Conference

  June 9, 2006

   · 

  1 min read
• Pharm Country

  Schering-Plough Corporation To Webcast CFO Robert J. Bertolini’s Presentation At Goldman Sachs 27th Annual Global Healthcare Conference

  June 9, 2006

   · 

  1 min read
• BioForest

  Seattle Genetics, Inc. To Present At Two Upcoming Investor Conferences

  June 9, 2006

   · 

  1 min read
• Deals

  SciClone Pharmaceuticals, Inc. Acquires Exclusive Rights In China To DC Bead Chemoembolization Device

  June 9, 2006

   · 

  5 min read
• Drug Development

  Questcor Pharmaceuticals, Inc. (Headquarters) Announces The Commercial Availability Of Doral(R) And Outlines Future Development Pipeline

  June 9, 2006

   · 

  1 min read
• Policy

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Files sNDA For VELCADE(R) (Bortezomib) For Injection In Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma

  June 9, 2006

   · 

  1 min read
• Deals

  Encore Medical Corporation Enters Agreement To Sell U.S. Consumer Product Line

  June 9, 2006

   · 

  2 min read
• FDA

  FDA Approves New Dosage Strengths For Novartis Corporation’s Lotrel(R)

  June 9, 2006

   · 

  6 min read